Intrinsic Value of S&P & Nasdaq Contact Us

Immunovant, Inc. IMVT NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
47/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$35.67
+34.4%

Immunovant, Inc. (IMVT) has 12 identified peers for comparison in the Healthcare sector. Peers include ABUS, ACLX, AKRO, AMLX, APLS, ARQT and others.

IMVT has a market capitalization of $5.4B, compared to an average peer market cap of $4.68B.

Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message